The expected launch of potential therapies may increase the Stargardt disease market size in the coming years, assisted by an increase in the diagnosed prevalent population. Owing to the positive outcomes of several products during the developmental stage by key players such as Alkeus…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.